14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 7th May 2024 OTLK stock ended at $8.21. This is 3.41% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 7.10% from a day low at $8.17 to a day high of $8.75.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Outlook Therapeutics Inc. prices

Date Open High Low Close Volume
Aug 25, 2023 $1.18 $1.20 $1.14 $1.16 2 450 004
Aug 24, 2023 $1.28 $1.28 $1.18 $1.19 3 349 089
Aug 23, 2023 $1.35 $1.35 $1.27 $1.28 932 951
Aug 22, 2023 $1.35 $1.37 $1.21 $1.27 1 975 378
Aug 21, 2023 $1.36 $1.38 $1.35 $1.37 1 426 488
Aug 18, 2023 $1.40 $1.41 $1.28 $1.33 3 306 377
Aug 17, 2023 $1.40 $1.44 $1.36 $1.43 1 199 959
Aug 16, 2023 $1.55 $1.55 $1.34 $1.36 3 475 790
Aug 15, 2023 $1.60 $1.60 $1.54 $1.55 896 009
Aug 14, 2023 $1.58 $1.58 $1.43 $1.57 2 281 127
Aug 11, 2023 $1.62 $1.64 $1.59 $1.60 1 093 406
Aug 10, 2023 $1.64 $1.70 $1.61 $1.61 1 150 012
Aug 09, 2023 $1.69 $1.69 $1.63 $1.64 608 415
Aug 08, 2023 $1.66 $1.68 $1.59 $1.67 1 021 311
Aug 07, 2023 $1.68 $1.68 $1.58 $1.64 942 760
Aug 04, 2023 $1.66 $1.68 $1.61 $1.63 984 193
Aug 03, 2023 $1.64 $1.66 $1.62 $1.65 534 348
Aug 02, 2023 $1.66 $1.68 $1.62 $1.65 1 001 706
Aug 01, 2023 $1.73 $1.73 $1.66 $1.67 728 188
Jul 31, 2023 $1.68 $1.74 $1.67 $1.73 859 796
Jul 28, 2023 $1.67 $1.69 $1.65 $1.66 557 069
Jul 27, 2023 $1.68 $1.72 $1.63 $1.65 671 801
Jul 26, 2023 $1.60 $1.65 $1.58 $1.62 704 781
Jul 25, 2023 $1.66 $1.68 $1.60 $1.61 710 621
Jul 24, 2023 $1.72 $1.73 $1.64 $1.68 1 022 646
Click to get the best stock tips daily for free!

About Outlook Therapeutics Inc.

Outlook Therapeutics. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice... OTLK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT